Response Biomedical 2011 Revenues Improve 32 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Response Biomedical said on Wednesday that full-year 2011 revenues rose 32 percent year over year, driven by growth in product sales.

Full-year revenues for the firm came in at C$9.5 million (US$9.5 million), up from C$7.1 million a year ago, as product sales also increased 32 percent year over year to C$9.0 million from C$6.8 million a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.